Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 50 | SFEBES2017 | Next issue

Society for Endocrinology BES 2017

Harrogate, UK
06 Nov 2017 - 08 Nov 2017

Card image cap
SfE BES 2017 will be on the 6-8 November 2016 in Harrogate, UK.

Symposia

Obesity for the Endocrinologist

ea0050s9.1 | Obesity for the Endocrinologist | SFEBES2017

New drug therapies for obesity: Do they work?

McGowan Barbara

Obesity is a chronic disease associated with a number of co-morbidities. Management options include lifestyle changes, pharmacotherapy and bariatric surgery. European guidelines recommend the use of pharmacotherapy for BMI ≥30 kg/m2 or BMI ≥27 kg/m2 with comorbidities in adjunct to lifestyle modification. Until 2015, orlistat was the only available medication for the treatment of obesity in Europe. Since then, further pharmacological agents ha...

ea0050s9.2 | Obesity for the Endocrinologist | SFEBES2017

Brain control of appetite

Heisler Lora

Obesity has emerged as one of the key health concerns of this century due to its prevalence and resistance to treatment. Specifically, more than 60% of people within the UK are currently overweight or obese. Recently, significant progress has been made in clarifying brain neurochemicals and regions regulating energy intake and energy expenditure. Among these neurochemicals is the precursor polypeptide pro-opiomelanocortin (Pomc) localised within the homeostatic brain region th...